13
Jan
2020
Phase II clinical trial of respiratory drug for treatment of Parkinson’s disease reveals promising results
NOTE: This release was originally published by The Cure Parkinson’s Trust. Results published today in the Journal of the American Medical Association... Read More
30
Jan
2019
Australian Government invests in innovative genomic testing in Linked Clinical Trials program
This story originally appeared on The Cure Parkinson’s Trust website. To learn more, click here. It was announced today that the... Read More
11
Oct
2018
ICYMI: Three big takeaways from Grand Challenges in Parkinson’s Disease
Did you miss Grand Challenges in Parkinson’s Disease and Rallying to the Challenge? Don’t worry. We have you covered. Just over a... Read More
12
Jul
2016
Michael J. Fox Foundation, Van Andel Research Institute and The Cure Parkinson’s Trust collaborate to assess the clinical use and development of nilotinib in Parkinson’s disease
Note: To read the commentary published in the Journal of Parkinson’s Disease click here. Investigators will focus on safety for long-term use in non-cancer... Read More
23
Sep
2014
Van Andel Research Institute joins The Cure Parkinson’s Trust to accelerate development of new Parkinson’s disease treatments
Grand Rapids, Mich. (Sept. 23, 2014) – Van Andel Research Institute (VARI) has partnered with UK-based research charity The Cure Parkinson’s Trust on... Read More
7
Aug
2014
Rallying to the Challenge meeting aims to improve Parkinson’s disease clinical trials
Meeting held in Grand Rapids, Mich., aims to increase the effectiveness and efficiency of the Parkinson’s disease clinical trial system Grand Rapids,... Read More